Comments on: BNT-325 by Duality Biologics (Shanghai) for Peritoneal Cancer: Likelihood of Approval /data-insights/bnt-325-duality-biologics-shanghai-peritoneal-cancer-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Tue, 21 Jan 2025 16:50:04 +0000 hourly 1 https://wordpress.org/?v=6.7.1